NPF Joins Maryland All Copays Count Coalition Letter in Support of HB 167

01/20/2021

The undersigned organizations write to you in support of HB 167 – Out-of-Pocket Maximums and CostSharing Requirements – Calculation. Our 26 organizations represent and care for Marylanders living with chronic and rare conditions who rely on high-cost specialty drugs. In recent years, health insurers have been implementing new programs called “copay accumulator adjustment programs” that do not count payments from copay assistance toward patients’ deductibles and out-of-pocket maximums. In other words, the assistance is not actually helping patients afford their high-cost treatments, forcing them to choose between their health and financial stability. HB 167 will help Marylanders continue to access the treatments they need by requiring that all payments made by or on behalf of a patient count toward their cost sharing obligations.

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorMy Psoriasis Team logo

Copyright © 1996-2021 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.